These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 20804928)

  • 21. Cost-effectiveness of revascularization for limb preservation in patients with end-stage renal disease.
    Barshes NR; Kougias P; Ozaki CK; Goodney PP; Belkin M
    J Vasc Surg; 2014 Aug; 60(2):369-374.e1. PubMed ID: 24657067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost utility of a multi-disciplinary foot protection clinic (MDFPC) in an Irish hospital setting.
    Nason GJ; Strapp H; Kiernan C; Moore K; Gibney J; Feeley TM; Egan B; Tierney S
    Ir J Med Sci; 2013 Mar; 182(1):41-5. PubMed ID: 22528251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the most effective way to reduce incidence of amputation in the diabetic foot?
    Apelqvist J; Larsson J
    Diabetes Metab Res Rev; 2000; 16 Suppl 1():S75-83. PubMed ID: 11054894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost Analysis of Initial Treatment With Endovascular Revascularization, Open Surgery, or Primary Major Amputation in Patients With Peripheral Artery Disease.
    Tang L; Paravastu SCV; Thomas SD; Tan E; Farmer E; Varcoe RL
    J Endovasc Ther; 2018 Aug; 25(4):504-511. PubMed ID: 29756521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated costs and high one-year mortality in patients with diabetic foot ulcers after surgery.
    Søndergaard LN; Christensen AB; Vinding AL; Kjær IL; Larsen P
    Dan Med J; 2015 Apr; 62(4):A5050. PubMed ID: 25872555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of diabetic foot ulcers.
    Vuorisalo S; Venermo M; Lepäntalo M
    J Cardiovasc Surg (Torino); 2009 Jun; 50(3):275-91. PubMed ID: 19543189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of a multidisciplinary outpatient team approach on outcomes in diabetic foot care: a single center study.
    Huizing E; Schreve MA; Kortmann W; Bakker JP; de Vries JPPM; Ünlü Ç
    J Cardiovasc Surg (Torino); 2019 Dec; 60(6):662-671. PubMed ID: 31603291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating Peripheral Artery Disease in the Wake of Rising Costs and Protracted Length of Stay.
    Wang GJ; Jackson BM; Foley PJ; Damrauer SM; Kalapatapu V; Golden MA; Fairman RM
    Ann Vasc Surg; 2017 Oct; 44():253-260. PubMed ID: 28479423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic limb salvage: too much of a good thing?
    Leon LR; Pacanowski J; Ranellone E; Armstrong D
    Vasc Endovascular Surg; 2010 Nov; 44(8):661-7. PubMed ID: 20675334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost comparison: limb salvage versus amputation in diabetic patients with charcot foot.
    Gil J; Schiff AP; Pinzur MS
    Foot Ankle Int; 2013 Aug; 34(8):1097-9. PubMed ID: 23493775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost and mortality data of a regional limb salvage and hyperbaric medicine program for Wagner Grade 3 or 4 diabetic foot ulcers.
    Eggert JV; Worth ER; Van Gils CC
    Undersea Hyperb Med; 2016; 43(1):1-8. PubMed ID: 27000008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A diabetic foot service established by a department of vascular surgery: an observational study.
    Williams DT; Majeed MU; Shingler G; Akbar MJ; Adamson DG; Whitaker CJ
    Ann Vasc Surg; 2012 Jul; 26(5):700-6. PubMed ID: 22503433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergent management of diabetic foot problems in the modern era: Improving outcomes.
    Troisi N; Bertagna G; Juszczak M; Canovaro F; Torri L; Adami D; Berchiolli R
    Semin Vasc Surg; 2023 Jun; 36(2):224-233. PubMed ID: 37330236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations.
    Ragnarson Tennvall G; Apelqvist J
    Diabetologia; 2001 Nov; 44(11):2077-87. PubMed ID: 11719840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. History of the team approach to amputation prevention: pioneers and milestones.
    Sanders LJ; Robbins JM; Edmonds ME
    J Vasc Surg; 2010 Sep; 52(3 Suppl):3S-16S. PubMed ID: 20804927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-economic consequences of diabetic foot lesions.
    Ragnarson Tennvall G; Apelqvist J
    Clin Infect Dis; 2004 Aug; 39 Suppl 2():S132-9. PubMed ID: 15306992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of Real-Life Endovascular Treatment of Critical Limb Ischemia: Report from Poland-A European Union Country with a Low-Budget Health Care System.
    Krzanowski M; Drelicharz L; Belowski A; Partyka L; Sumek-Brandys B; Ramakrishnan PK; Nizankowski R
    Ann Vasc Surg; 2016 Feb; 31():111-23. PubMed ID: 26616505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The economic burden of inpatient diabetic foot ulcers in Toronto, Canada.
    Syed MH; Salata K; Hussain MA; Zamzam A; de Mestral C; Wheatcroft M; Harlock J; Awartani D; Aljabri B; Verma A; Razak F; Verma S; Al-Omran M
    Vascular; 2020 Oct; 28(5):520-529. PubMed ID: 32379584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness of Lower Extremity Nerve Decompression Surgery in the Prevention of Ulcers and Amputations: A Markov Analysis.
    Rinkel WD; Franks B; Birnie E; Castro Cabezas M; Coert JH
    Plast Reconstr Surg; 2021 Nov; 148(5):1135-1145. PubMed ID: 34705790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model to estimate cost-savings in diabetic foot ulcer prevention efforts.
    Barshes NR; Saedi S; Wrobel J; Kougias P; Kundakcioglu OE; Armstrong DG
    J Diabetes Complications; 2017 Apr; 31(4):700-707. PubMed ID: 28153676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.